Highly rated in
Highly rated in
Check Dr. Merit E. Cudkowicz's experience treating your condition:
About Dr. Merit E. Cudkowicz

Merit Cudkowicz is a Neurologist in Boston, Massachusetts. Cudkowicz has been practicing medicine for over 33 years and is highly rated in 10 conditions, according to our data. Her top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Parkinson's Disease, and Dementia. She is licensed to treat patients in Massachusetts. Cudkowicz is currently accepting new patients.

Her clinical research consists of co-authoring 198 peer reviewed articles and participating in 21 clinical trials in the past 15 years.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Merit E. Cudkowicz it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Dr. Merit E. Cudkowicz accepts the following insurance:

  •  Ambetter
  •  Anthem
15 Parkman St, Wacc 729j, Boston, MA 02114
Other Locations
165 Cambridge St, Boston, MA 02114
Background & Education
Graduate Institution
Harvard Medical School, 1990
Psychiatry & Neurology in MA
Hospital Affiliations
Parkland Medical Center
Massachusetts General Hospital
Newton-Wellesley Hospital
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

21 Clinical Trials

HEALEY ALS Platform Trial
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
An Open-Label, Safety and Tolerability, Study Evaluating KNS-760704 in Patients With Amyotrophic Lateral Sclerosis (ALS)
A Multi-Center, Double-Blind, Pilot Study of Minocycline in Huntington's Disease
Phase II/III Randomized, Placebo-Controlled Trial of Arimoclomol in SOD1 Positive Familial Amyotrophic Lateral Sclerosis (ALS)
Coenzyme Q10 in Huntington's Disease (HD)
GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS)
An Intermediate Expanded Access Protocol for Amyotrophic Lateral Sclerosis With CNM-Au8
HEALEY ALS Platform Trial - Regimen E SLS-005 - Trehalose
HEALEY ALS Platform Trial - Regimen D Pridopidine
Clinical Trial Ceftriaxone in Subjects With Amyotrophic Lateral Sclerosis (ALS)
The Experimental Treatment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis (ALS)
HEALEY ALS Platform Trial - Regimen A Zilucoplan
A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in Amyotrophic Lateral Sclerosis (ALS)
HEALEY ALS Platform Trial - Regimen C CNM-Au8
HEALEY ALS Platform Trial - Regimen B Verdiperstat
View 19 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors